FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Mavacamten is the first ever drug to be approved for HOCM found to improve symptoms and may reduce the need for surgery for some people.
Source: everydayhealth.com
Underlying Disease Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Underlying Disease Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Underlying Disease Process Today - Breaking & Trending Today